249 related articles for article (PubMed ID: 16857907)
1. Intellectual property. Groups challenge key stem cell patents.
Kintisch E
Science; 2006 Jul; 313(5785):281. PubMed ID: 16857907
[No Abstract] [Full Text] [Related]
2. Science and law. Intellectual property and human embryonic stem cell research.
Loring JF; Campbell C
Science; 2006 Mar; 311(5768):1716-7. PubMed ID: 16556826
[No Abstract] [Full Text] [Related]
3. The paths around stem cell intellectual property.
Taymor KS; Scott CT; Greely HT
Nat Biotechnol; 2006 Apr; 24(4):411-3. PubMed ID: 16601720
[TBL] [Abstract][Full Text] [Related]
4. European patents. Stem cell claims face legal hurdles.
Vogel G
Science; 2004 Sep; 305(5692):1887. PubMed ID: 15448234
[No Abstract] [Full Text] [Related]
5. Bill to ban patents on human organisms nears congressional approval.
Brainard J
Chron High Educ; 2003 Dec; 50(15):A17. PubMed ID: 15287137
[No Abstract] [Full Text] [Related]
6. Burning bridges.
Nat Biotechnol; 2007 Jan; 25(1):2. PubMed ID: 17211373
[TBL] [Abstract][Full Text] [Related]
7. Who owns my DNA?: the national and international intellectual property law on human embryonic tissue and cloning.
Knowles SM; Adams SD
Cumberland Law Rev; 2001-2002; 32(3):475-86. PubMed ID: 12645552
[No Abstract] [Full Text] [Related]
8. A call to legal arms: bringing embryonic stem cell therapies to market.
Miller J
Albany Law J Sci Technol; 2003; 13(2):555-92. PubMed ID: 15199929
[No Abstract] [Full Text] [Related]
9. The gatekeepers of hES cell products.
Rabin S
Nat Biotechnol; 2005 Jul; 23(7):817-9. PubMed ID: 16003363
[No Abstract] [Full Text] [Related]
10. Biomedical research. States, foundations lead the way after Bush vetoes stem cell bill.
Holden C
Science; 2006 Jul; 313(5786):420-1. PubMed ID: 16873614
[No Abstract] [Full Text] [Related]
11. Patent protection for stem cell procedures under the law of the European Union.
Spranger TM
Med Etika Bioet; 2003; 10(1-2):4-8. PubMed ID: 16294439
[TBL] [Abstract][Full Text] [Related]
12. Challenges to human embryonic stem cell patents.
Plomer A; Taymor KS; Scott CT
Cell Stem Cell; 2008 Jan; 2(1):13-7. PubMed ID: 18371416
[TBL] [Abstract][Full Text] [Related]
13. U.S. concedes some cell lines are not ready.
Stolberg SG
N Y Times Web; 2001 Sep; ():A1, A20. PubMed ID: 12156306
[No Abstract] [Full Text] [Related]
14. Ethical questions to ponder in the European stem cell patent debate.
Curley D; Sharples A
J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135
[TBL] [Abstract][Full Text] [Related]
15. Supporting the work of lesser geniuses: an argument for removing obstructions to human embryonic stem cell research.
Hazuka CD
Univ Miami Law Rev; 2002 Oct; 57(1):157-220. PubMed ID: 15156896
[No Abstract] [Full Text] [Related]
16. Europe halts decisions on stem-cell patents.
Schubert S
Nature; 2005 Jun; 435(7043):720-1. PubMed ID: 15944658
[No Abstract] [Full Text] [Related]
17. Stem cell research. Senate prepares to vote at last on a trio of stem cell bills.
Holden C
Science; 2006 Jul; 313(5783):26-7. PubMed ID: 16825539
[No Abstract] [Full Text] [Related]
18. Error of judgment.
Nature; 2011 Dec; 480(7377):291-2. PubMed ID: 22170640
[No Abstract] [Full Text] [Related]
19. NIH sacrifices commercial rights in WiCell deal.
Robertson D
Nat Biotechnol; 2001 Nov; 19(11):1001. PubMed ID: 11689833
[No Abstract] [Full Text] [Related]
20. Patent prosecution strategies for stem cell related applications.
Kumar R; Yeh JJ; Fernandez D; Hansen N
J Biomol Screen; 2007 Sep; 12(6):769-74. PubMed ID: 17848639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
